A Phase 2 clinical trial, DOREMY, investigates the effects of dose reduction in preoperative radiotherapy for myxoid liposarcoma. The study aims to optimize treatment while maintaining efficacy in this rare cancer type.
dose reduction of preoperative radiotherapy in myxoid liposarcoma the phase 2 doremy nonrandomized clinical trial
Original title: “Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial.”